A Case of Nonsmall-Cell Lung Cancer with Anaphylaxis after 41 Courses of Pembrolizumab along with Adrenal Insufficiency as an Immune-Related Adverse Event

In this report, we present a case of nonsmall-cell lung cancer with anaphylaxis after 41 courses of pembrolizumab along with adrenal insufficiency as an immune-related adverse event (irAE). A 73-year-old man with no allergic disease started pembrolizumab for postoperative recurrence of lung cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tomoaki, Imai, Ryosuke, Nishimura, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941790/
https://www.ncbi.nlm.nih.gov/pubmed/36825102
http://dx.doi.org/10.1159/000526561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941790/
https://www.ncbi.nlm.nih.gov/pubmed/36825102
http://dx.doi.org/10.1159/000526561

Ejemplares similares